Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

Blood (2022) 140 (5): 419–437.

https://doi.org/10.1182/blood.2021012057

Published: 2022

Journal Articles

Outcomes of rare patients with a primary cutaneous CD30 + lymphoproliferative disorder developing extracutaneous disease

Rutger C. Melchers, Rein Willemze, Joost S. P. Vermaat, Patty M. Jansen, Laurien A. Daniëls, Hein Putter, Marcel W. Bekkenk, Ellen R. M. de Haas, Barbara Horvath, Michelle M. van Rossum, Cornelus J. G. Sanders, Joep C. J. M. Veraart, Maarten H. Vermeer, Koen D. Quint

Blood (2020) 135 (10): 769–773.

https://doi.org/10.1182/blood.2019002799

Published: 2020

Includes: Supplemental data

Journal Articles

The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas

Rein Willemze, Lorenzo Cerroni, Werner Kempf, Emilio Berti, Fabio Facchetti, Steven H. Swerdlow, Elaine S. Jaffe

Blood (2019) 133 (16): 1703–1714.

https://doi.org/10.1182/blood-2018-11-881268

Published: 2019

Journal Articles

Primary Cutaneous Follicle Center Lymphomas (PCFCL) Express Heavily Mutated B-Cell Receptors with Acquired N-Glycosylation Motifs and Lack Ongoing Somatic Hypermutation

Marvyn T. Koning, BSc, Edwin Quinten, Willem H. Zoutman, Sander A.J. van der Zeeuw, Szymon M. Kielbasa, PhD, Hailang Mei, PhD, Cornelis A.M. van Bergen, PhD, Patty M. Jansen, MD PhD, Rein Willemze, MD PhD, Christian Schmidt, MD, Maarten Vermeer, MD PhD, Cornelis P. Tensen, PhD, Hendrik Veelken, MD PhD

Blood (2018) 132 (Supplement 1): 1573.

https://doi.org/10.1182/blood-2018-99-115134

Published: 2018

Journal Articles

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

Blood (2018) 131 (18): 2086–2089.

https://doi.org/10.1182/blood-2017-12-822817

Published: 2018

Includes: Supplemental data

Journal Articles

Antigen-Independent, Autonomous B-Cell Receptor Signaling As a Dominant Candidate Oncogenic Mechanism in ABC DLBCL

Marvyn T. Koning, BSc, Rudolf Übelhart, PhD, Arjen H.G. Cleven, PhD, Willem H. Zoutman, BSc, Sander A.J. van der Zeeuw, BSc, Philip Kluin, MD PhD, Marieke Griffioen, PhD, Cornelis P. Tensen, PhD, Maarten H. Vermeer, MD PhD, Rein Willemze, MD PhD, Szymon M. Kielbasa, PhD, Marcelo A. Navarrete, MD PhD, Hassan Jumaa, PhD, Hendrik Veelken, MD PhD

Blood (2016) 128 (22): 778.

https://doi.org/10.1182/blood.V128.22.778.778

Published: 2016

Journal Articles

The B-Cell Receptor of Primary Cutaneous Follicle Center Lymphoma: Implications for Pathogenesis

Marvyn T. Koning, BSc, Sander A.J. van der Zeeuw, BSc, Willem H. Zoutman, BSc, Maarten H. Vermeer, MD PhD, Rein Willemze, MD PhD, Hendrik Veelken, MD PhD, Cornelis P. Tensen, PhD

Blood (2016) 128 (22): 4136.

https://doi.org/10.1182/blood.V128.22.4136.4136

Published: 2016

Journal Articles

No TP63 rearrangements in a selected group of primary cutaneous CD30 + lymphoproliferative disorders with aggressive clinical course

Anne M. R. Schrader, Yan-Yi Chung, Patty M. Jansen, Karoly Szuhai, Armando N. Bastidas Torres, Cornelis P. Tensen, Rein Willemze

Blood (2016) 128 (1): 141–143.

https://doi.org/10.1182/blood-2016-02-694455

Published: 2016

Journal Articles

Limited effect of chemotherapy in cutaneous lymphoma

Maarten H. Vermeer, Rein Willemze

Blood (2015) 125 (1): 4–5.

https://doi.org/10.1182/blood-2014-11-609305

Published: 2015

Journal Articles

Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases

Marchina F. Benner, Patty M. Jansen, Maarten H. Vermeer, Rein Willemze

Blood (2012) 119 (7): 1643–1649.

https://doi.org/10.1182/blood-2011-08-376319

Published: 2012

Journal Articles

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

Blood (2011) 118 (15): 4024–4035.

https://doi.org/10.1182/blood-2011-05-351346

Published: 2011

Journal Articles

Oncogenomic analysis of mycosis fungoides reveals major differences with Sézary syndrome

Remco van Doorn, Marloes S. van Kester, Remco Dijkman, Maarten H. Vermeer, Aat A. Mulder, Karoly Szuhai, Jeroen Knijnenburg, Judith M. Boer, Rein Willemze, Cornelis P. Tensen

Blood (2009) 113 (1): 127–136.

https://doi.org/10.1182/blood-2008-04-153031

Published: 2009

Includes: Supplemental data

Journal Articles

The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment

Febe van Maldegem, Remco van Dijk, Thera A. M. Wormhoudt, Philip M. Kluin, Rein Willemze, Lorenzo Cerroni, Carel J. M. van Noesel, Richard J. Bende

Blood (2008) 112 (8): 3355–3361.

https://doi.org/10.1182/blood-2008-01-132415

Published: 2008

Includes: Supplemental data

Journal Articles

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas

Nancy J. Senff, Evert M. Noordijk, Youn H. Kim, Martine Bagot, Emilio Berti, Lorenzo Cerroni, Reinhard Dummer, Madeleine Duvic, Richard T. Hoppe, Nicola Pimpinelli, Steven T. Rosen, Maarten H. Vermeer, Sean Whittaker, Rein Willemze

Blood (2008) 112 (5): 1600–1609.

https://doi.org/10.1182/blood-2008-04-152850

Published: 2008

Journal Articles

Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases

Blood (2008) 111 (2): 838–845.

https://doi.org/10.1182/blood-2007-04-087288

Published: 2008

Journal Articles

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

Blood (2007) 110 (6): 1713–1722.

https://doi.org/10.1182/blood-2007-03-055749

Published: 2007

Includes: Supplemental data

Journal Articles

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

Youn H. Kim, Rein Willemze, Nicola Pimpinelli, Sean Whittaker, Elise A. Olsen, Annamari Ranki, Reinhard Dummer, Richard T. Hoppe

Blood (2007) 110 (2): 479–484.

https://doi.org/10.1182/blood-2006-10-054601

Published: 2007

Includes: Supplemental data

Journal Articles

Gene-expression profiling and array-based CGH classify CD4 + CD56 + hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities

Remco Dijkman, Remco van Doorn, Károly Szuhai, Rein Willemze, Maarten H. Vermeer, Cornelis P. Tensen

Blood (2006) 109 (4): 1720–1727.

https://doi.org/10.1182/blood-2006-04-018143

Published: 2006

Includes: Supplemental data

Journal Articles

Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID

Remco Dijkman, Cornelis P. Tensen, Maike Buettner, Gerald Niedobitek, Rein Willemze, Maarten H. Vermeer

Blood (2006) 107 (12): 4926–4929.

https://doi.org/10.1182/blood-2005-08-3443

Published: 2006

Includes: Supplemental data

Journal Articles

WHO-EORTC classification for cutaneous lymphomas

Blood (2005) 105 (10): 3768–3785.

https://doi.org/10.1182/blood-2004-09-3502

Published: 2005

NARROW

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

Outcomes of rare patients with a primary cutaneous CD30 + lymphoproliferative disorder developing extracutaneous disease

The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas

Primary Cutaneous Follicle Center Lymphomas (PCFCL) Express Heavily Mutated B-Cell Receptors with Acquired N-Glycosylation Motifs and Lack Ongoing Somatic Hypermutation

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

Antigen-Independent, Autonomous B-Cell Receptor Signaling As a Dominant Candidate Oncogenic Mechanism in ABC DLBCL

The B-Cell Receptor of Primary Cutaneous Follicle Center Lymphoma: Implications for Pathogenesis

No TP63 rearrangements in a selected group of primary cutaneous CD30 + lymphoproliferative disorders with aggressive clinical course

Limited effect of chemotherapy in cutaneous lymphoma

Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

Oncogenomic analysis of mycosis fungoides reveals major differences with Sézary syndrome

The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas

Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

Gene-expression profiling and array-based CGH classify CD4 + CD56 + hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities

Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID

WHO-EORTC classification for cutaneous lymphomas

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only